A Clinical Trial to Evaluate the Safety and Immunogenicity of a Single Dose of Adsorbed Tetanus Vaccine in a Population Aged 18 Years and Over
Clinical trial NCT06120751 · COMPLETED
Trial details
- NCT number
- NCT06120751
- Sponsor
- CanSino Biologics Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-20
- Primary completion
- 2024-04-30
- Enrollment
- 1000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.